Statistics

Total Visits

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial34

Select a period of time:

Number of views in the range

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial19

Views

Views
January 20250
February 20250
March 202517
April 20252
May 20250
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Spain1
United States1
 

Top cities views

Views
Council Bluffs1